Unlock groundbreaking opportunities in drug discovery with the power of proprietary datasets. The Eurofins DiscoveryAI EMERALD (Exclusive Machine Learning Resource Leveraging Data as a Service) curated datasets feature a collection of robust, time-tested assays against critical pharmaceutical targets. Featuring a foundational collection of drugs, drug failures, and pharmacological tools, the EMERALD database enables the training of your computational models with relevant high-quality proprietary data. EMERALD data occupies similar chemical space to current market drugs, making it an attractive training set that was generated from standardized assay protocols.
Secure access is available now. EMERALD packages include:
- ADME: over 20,000 ADME data points from the Eurofins Discovery proprietary data collection.
- Potency: Nearly 500,000 potency data points from the Eurofins Discovery proprietary data collection.
- Curated data only: highly curated public data with over 100,000 data points for ADME and potency.
- All available data: All proprietary and highly curated public data for ADME and potency.
